Literature DB >> 7478553

Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos.

L Buday1, P H Warne, J Downward.   

Abstract

Formation of a complex of the nucleotide exchange factor Sos, the SH2 and SH3 containing adaptor protein Grb2/Sem-5 and tyrosine phosphorylated EGF receptor and Shc has been implicated in the activation of Ras by epidermal growth factor (EGF) in fibroblasts: related mechanisms for activation of Ras operate in other cell types. An increase in the apparent molecular weight of Sos has been reported to occur after several minutes of receptor stimulation due to phosphorylation by mitogen-activated protein (MAP) kinases. We report here that treatment of human peripheral blood T lymphoblasts with phorbol esters causes a similar shift in mobility of Sos. This modification of Sos does not alter its ability to bind Grb2, but correlates with strong inhibition of the binding of the Sos/Grb2 complex to tyrosine phosphorylated sequences, either a tyrosine phosphopeptide in cell lysates or p36 in intact cells. This effect, along with the mobility shift of Sos, can be mimicked in vitro by phosphorylation of Sos by the mitogen-activated protein kinase, ERK1. A novel negative feedback mechanism therefore exists whereby activation of MAP kinases through Ras results in the uncoupling of the Sos/Grb2 complex from tyrosine kinase substrates without blocking the interaction of Sos with Grb2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478553

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

Review 1.  MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer.

Authors:  Sriganesh B Sharma; John Michael Ruppert
Journal:  Drug Dev Res       Date:  2015-08-18       Impact factor: 4.360

2.  Biology using engineering tools: the negative feedback amplifier.

Authors:  Marc R Birtwistle; Walter Kolch
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

3.  Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisions.

Authors:  Marcel Schilling; Thomas Maiwald; Stefan Hengl; Dominic Winter; Clemens Kreutz; Walter Kolch; Wolf D Lehmann; Jens Timmer; Ursula Klingmüller
Journal:  Mol Syst Biol       Date:  2009-12-22       Impact factor: 11.429

Review 4.  Visualization of the spatial and temporal dynamics of MAPK signaling using fluorescence imaging techniques.

Authors:  Taichiro Tomida
Journal:  J Physiol Sci       Date:  2014-08-22       Impact factor: 2.781

Review 5.  Insulin regulation of the Ras activation/inactivation cycle.

Authors:  B P Ceresa; J E Pessin
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 6.  Four-dimensional dynamics of MAPK information processing systems.

Authors:  Boris N Kholodenko; Marc R Birtwistle
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

7.  Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2.

Authors:  S Corbalan-Garcia; S S Yang; K R Degenhardt; D Bar-Sagi
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.

Authors:  Federica Catalanotti; Gloria Reyes; Veronika Jesenberger; Gergana Galabova-Kovacs; Ricardo de Matos Simoes; Oliviero Carugo; Manuela Baccarini
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

Review 9.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.

Authors:  D T Denhardt
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation.

Authors:  Stephanie J Moeller; Elizabeth D Head; Robert J Sheaff
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.